Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/AYR.A stock hub

CSE/AYR.A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/AYR.Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.9M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/AYR.A

In the news

Latest news · CSE/AYR.A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-68

P25 -121.5P50 -40.9P75 0.5

ROIC-6.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/AYR.A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	2,500
Employees Change	60%
Employees Change Percent	2.46
Enterprise value	CAD 841.5M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CAD 18.9M
Price	CAD 0.16
Price currency	CAD
Rev Per Employee	260,389.75x
Sector	Healthcare
Sic	2834
Symbol	cse/AYR.A
Website	https://www.ayrwellness.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2,359.61%
EV Earnings	-1.89x
EV/EBITDA	12.92x
EV/FCF	-65.39x
EV/Sales	1.29x
FCF yield	-68.07%
P/B ratio	0.04x
P/S ratio	0.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.73%
EBITDA Margin	4.48%
Gross margin	35.07%
Gross Profit	CAD 228.3M
Gross Profit Growth	-22.46%
Gross Profit Growth Q	-35.23%
Gross Profit Growth3 Y	-6.54%
Gross Profit Growth5 Y	27.74%
Net Income	CAD -446.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-58.64%
Profit Margin	-68.53%
Profit Per Employee	CAD -178,445
ROA	-2.64
Roa5y	-1.01
ROCE	-6.48
ROE	-67.99
Roe5y	-25.51
ROIC	-6.21
Roic5y	-1.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.83%
Cagr3y	-72.61%
Cagr5y	-57.17%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth Q	1,400.25%
OCF Growth	-54.35%
OCF Growth Q	23.62%
OCF Growth5 Y	1.78%
Revenue Growth	-2.39x
Revenue Growth Q	-9.09x
Revenue Growth Years	1x
Revenue Growth3 Y	4.34x
Revenue Growth5 Y	33.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.33
Assets	CAD 1.8B
Cash	CAD 54.1M
Current Assets	CAD 246.1M
Current Liabilities	CAD 499.6M
Debt	CAD 911.7M
Debt EBITDA	CAD 14
Debt Equity	CAD 2.05
Debt FCF	CAD -70.85
Equity	CAD 444.6M
Interest Coverage	-0.71
Liabilities	CAD 1.4B
Long Term Assets	CAD 1.6B
Long Term Liabilities	CAD 861.1M
Net Cash	CAD -857.6M
Net Cash By Market Cap	CAD -4,536
Net Debt EBITDA	CAD 29.43
Net Debt Equity	CAD 1.93
Tangible Book Value	CAD -388M
Tangible Book Value Per Share	CAD -3.32
WACC	10.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.49
Inventory Turnover	2.64
Net Working Capital	CAD 85M
Quick ratio	0.14
Working Capital	CAD -266.5M
Working Capital Turnover	CAD -15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-42.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.82%
200-day SMA	1.1
3Y total return	-97.95%
50-day SMA	0.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.56%
All Time High	47.14
All Time High Change	-99.67%
All Time High Date	2021-02-10
All Time Low	0.12
All Time Low Change	29.17%
All Time Low Date	2025-06-02
ATR	0.04
Beta	1.01
Beta1y	-0.35
Beta2y	1.41
Ch YTD	-76.15
High	0.16
High52	3.6
High52 Date	2024-10-23
High52ch	-95.69%
Low	0.15
Low52	0.12
Low52 Date	2025-06-02
Low52ch	29.17%
Ma50ch	-44.04%
Price vs 200-day SMA	-85.95%
RSI	29.79
RSI Monthly	35.71
RSI Weekly	32.28
Sharpe ratio	-1.16x
Sortino ratio	-1.45
Total Return	-42.55%
Tr YTD	-76.15
Tr1m	-62.2%
Tr1w	-48.33%
Tr3m	-59.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -82.9M
Operating margin	-12.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-36,615,067.2
Shares Insiders	1.34%
Shares Institutions	5.1%
Shares Out	121,975,416
Shares Qo Q	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -36.5M
Average Volume	103,759.4x
Bv Per Share	3.99
CAPEX	CAD -29.7M
Ch1m	-62.2
Ch1w	-48.33
Ch1y	-94.82
Ch3m	-59.21
Ch3y	-97.95
Ch5y	-98.56
Ch6m	-78.17
Change	0%
Change From Open	0
Close	0.16
Days Gap	0
Depreciation Amortization	106,556,079.3
Dollar Volume	16,277.3
Earnings Date	2026-05-14
EBIT	CAD -82.9M
EBITDA	CAD 29.1M
EPS	CAD -3.86
F Score	4
FCF	CAD -12.9M
FCF EV Yield	-1.53x
FCF Per Share	CAD -0.11
Financing CF	-38,663,278
Fiscal Year End	December
Founded	2,017
Income Tax	CAD 66M
Investing CF	-26,366,748
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-03-31
Ma150	0.6
Ma150ch	-74.15%
Ma20	0.29
Ma20ch	-46.92%
Net CF	-48,238,903
Next Earnings Date	2026-05-14
Open	0.16
P OCF Ratio	1.13
Position In Range	50
Ppne	648,081,494.7
Price Date	2025-06-05
Price EBITDA	CAD 0.65
Relative Volume	1.01x
Revenue	650,974,378x
SBC By Revenue	3.63x
Share Based Comp	23,661,656
Tax By Revenue	10.13x
Tr6m	-78.17%
Volume	105,015
Z Score	-1.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/AYR.A pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/AYR.A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/AYR.A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.1%

Share of float held by funds and institutions

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

CSE/AYR.A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.8

Below 30: short-term oversold

Price vs 200-day MA

-85.9%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

-1.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/AYR.A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/AYR.A stock rating?

cse/AYR.A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/AYR.A analysis?

The full report lives at /stocks/cse/AYR.A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/AYR.A?

The latest report frames cse/AYR.A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/AYR.A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.